Board of trustees

The boards of trustees of the individual Fraunhofer Institutes act as purely advisory bodies to their institute’s management. The members come from academia, industry, and government agencies. The Fraunhofer ITEM board of trustees is made up of the following members:

Dr. Eckhard von Keutz
Chairman of the board of trustees
Senior Vice President, Global Head Early Development
Bayer HealthCare AG

Prof. Christopher Baum
Deputy Chairman of the board of trustees
President and member of the Presidential Council responsible for the Division of Research and Teaching of the Hannover Medical School

Dr. Marcus Beiner
Deputy Head of the Department Research and Innovation, Head of the Division of Life Sciences, Humanities, Social Sciences, and Sustainable Development, Lower Saxony Ministry of Science and Culture

Prof. Paul-Georg Germann
Head of Global Non-clinical Safety
Merck KGaA

Prof. Edith M. Hessel
Vice President and Head Refractory Respiratory Inflammation Discovery Performance Unit
GlaxoSmithKline UK

Prof. Michael Hildebrand
Executive Director
Hildebrand Pharma Consulting

Dr. Frank Kalkbrenner
Executive Director
Boehringer Ingelheim Corporate Venture Fund

Prof. Thomas Lenarz
Professor and Chairman of the Department of Otorhinolaryngology, and Director of Deutsches HörZentrum
Hannover Medical School

Dr. Torsten Wagner
Senior Vice President, Corporate Technical Operations
Merz Pharma GmbH & Co. KGaA